Clinical Trial Update: A Phase II Study in Patients With Alopecia Areata [Phase 2]

View source ↗

Summary

A Phase II study in patients with alopecia areata has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED